Cannabinoid Hyperemesis Syndrome

Definition

Cannabinoid Hyperemesis Syndrome (CHS) is a medical condition characterized by recurrent episodes of severe nausea, vomiting, and abdominal pain in individuals who use cannabis chronically. A unique paradox, CHS tends to affect long-term cannabis users—even those who initially used the substance to alleviate nausea or anxiety. Symptoms often emerge after years of regular use and are typically relieved by taking hot showers or baths, which provide temporary comfort through heat-triggered nerve responses. While CHS is still being researched, it’s believed to involve dysfunction in the body’s endocannabinoid system, particularly when overwhelmed by prolonged THC exposure. The condition can be debilitating, leading to dehydration, emergency room visits, and a significant impact on daily life. Diagnosis is often delayed, as many users and even healthcare providers are unaware of the link between cannabis and these symptoms. The only known effective treatment is cannabis cessation, which usually leads to full symptom resolution. For those in recovery or harm reduction programs, understanding CHS is critical to making informed choices about cannabis use. Education and compassionate support can help clients navigate this lesser-known but serious side effect of long-term cannabis consumption.

Synonyms

CHS, Cannabis-Induced Vomiting, Cyclical Nausea Syndrome, THC Overuse Reaction, Marijuana-Related Illness

Usage Examples

Despite using cannabis daily for anxiety, he developed cannabinoid hyperemesis syndrome and was hospitalized multiple times before the cause was recognized.

Historical Background

CHS was first identified in the early 2000s, as emergency physicians began documenting patterns of severe vomiting in chronic cannabis users. Due to cannabis’s reputation for treating nausea, CHS was initially misunderstood or misdiagnosed. Research has since linked the syndrome to overactivation of cannabinoid receptors in the gut and brain. As legalization has expanded cannabis access, clinicians have become more attuned to CHS symptoms, especially in young adults presenting with unexplained gastrointestinal distress.

Related Questions

Share your support for mental health